These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 12799276)
1. New models to investigate mechanisms of disease genesis from primitive BCR-ABL(+) hematopoietic cells. Eaves C; Jiang X; Eisterer W; Chalandon Y; Porada G; Zanjani E; Eaves A Ann N Y Acad Sci; 2003 May; 996():1-9. PubMed ID: 12799276 [TBL] [Abstract][Full Text] [Related]
2. Primitive quiescent leukemic cells from patients with chronic myeloid leukemia spontaneously initiate factor-independent growth in vitro in association with up-regulation of expression of interleukin-3. Holyoake TL; Jiang X; Jorgensen HG; Graham S; Alcorn MJ; Laird C; Eaves AC; Eaves CJ Blood; 2001 Feb; 97(3):720-8. PubMed ID: 11157490 [TBL] [Abstract][Full Text] [Related]
3. Primitive interleukin 3 null hematopoietic cells transduced with BCR-ABL show accelerated loss after culture of factor-independence in vitro and leukemogenic activity in vivo. Jiang X; Ng E; Yip C; Eisterer W; Chalandon Y; Stuible M; Eaves A; Eaves CJ Blood; 2002 Nov; 100(10):3731-40. PubMed ID: 12393460 [TBL] [Abstract][Full Text] [Related]
4. Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR/ABL. Li S; Gillessen S; Tomasson MH; Dranoff G; Gilliland DG; Van Etten RA Blood; 2001 Mar; 97(5):1442-50. PubMed ID: 11222392 [TBL] [Abstract][Full Text] [Related]
5. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells. Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115 [TBL] [Abstract][Full Text] [Related]
7. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Eisterer W; Jiang X; Christ O; Glimm H; Lee KH; Pang E; Lambie K; Shaw G; Holyoake TL; Petzer AL; Auewarakul C; Barnett MJ; Eaves CJ; Eaves AC Leukemia; 2005 Mar; 19(3):435-41. PubMed ID: 15674418 [TBL] [Abstract][Full Text] [Related]
8. Evidence for a positive role of SHIP in the BCR-ABL-mediated transformation of primitive murine hematopoietic cells and in human chronic myeloid leukemia. Jiang X; Stuible M; Chalandon Y; Li A; Chan WY; Eisterer W; Krystal G; Eaves A; Eaves C Blood; 2003 Oct; 102(8):2976-84. PubMed ID: 12829595 [TBL] [Abstract][Full Text] [Related]
9. The effect of Bcr-Abl protein tyrosine kinase on maturation and proliferation of primitive haematopoietic cells. Buckle AM; Mottram R; Pierce A; Lucas GS; Russell N; Miyan JA; Whetton AD Mol Med; 2000 Oct; 6(10):892-902. PubMed ID: 11126203 [TBL] [Abstract][Full Text] [Related]
10. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia. Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497 [TBL] [Abstract][Full Text] [Related]
11. Autocrine and paracrine effects of an ES-cell derived, BCR/ABL-transformed hematopoietic cell line that induces leukemia in mice. Peters DG; Klucher KM; Perlingeiro RC; Dessain SK; Koh EY; Daley GQ Oncogene; 2001 May; 20(21):2636-46. PubMed ID: 11420675 [TBL] [Abstract][Full Text] [Related]
13. [A preliminary study on mechanisms for resistance of CML patient BM-derived bcr/abl+ and Flk1+CD31-CD34- stem cells to STI571 in vitro]. Song YP; Fang BJ; Wei XD; Zheng S Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Dec; 13(6):1004-9. PubMed ID: 16403268 [TBL] [Abstract][Full Text] [Related]
14. BMI1 collaborates with BCR-ABL in leukemic transformation of human CD34+ cells. Rizo A; Horton SJ; Olthof S; Dontje B; Ausema A; van Os R; van den Boom V; Vellenga E; de Haan G; Schuringa JJ Blood; 2010 Nov; 116(22):4621-30. PubMed ID: 20724541 [TBL] [Abstract][Full Text] [Related]
15. BCR-ABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Bedi A; Zehnbauer BA; Collector MI; Barber JP; Zicha MS; Sharkis SJ; Jones RJ Blood; 1993 Jun; 81(11):2898-902. PubMed ID: 8499629 [TBL] [Abstract][Full Text] [Related]
16. Role of BCR-ABL-Y177-mediated p27kip1 phosphorylation and cytoplasmic localization in enhanced proliferation of chronic myeloid leukemia progenitors. Chu S; McDonald T; Bhatia R Leukemia; 2010 Apr; 24(4):779-87. PubMed ID: 20200561 [TBL] [Abstract][Full Text] [Related]
17. Growth autonomy and lineage switching in BCR-ABL-transduced human cord blood cells depend on different functional domains of BCR-ABL. Chalandon Y; Jiang X; Loutet S; Eaves AC; Eaves CJ Leukemia; 2004 May; 18(5):1006-12. PubMed ID: 15014528 [TBL] [Abstract][Full Text] [Related]
18. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL. Aljedai A; Buckle AM; Hiwarkar P; Syed F PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484 [TBL] [Abstract][Full Text] [Related]